{"id":"https://openalex.org/W1985018554","doi":"https://doi.org/10.1074/jbc.m701866200","title":"Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors","display_name":"Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-24","ids":{"openalex":"https://openalex.org/W1985018554","doi":"https://doi.org/10.1074/jbc.m701866200","mag":"1985018554","pmid":"https://pubmed.ncbi.nlm.nih.gov/17452318"},"language":"en","primary_location":{"id":"doi:10.1074/jbc.m701866200","doi":"https://doi.org/10.1074/jbc.m701866200","is_oa":true,"landing_page_url":"https://doi.org/10.1074/jbc.m701866200","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1985018554"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1074/jbc.m701866200","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110484231","display_name":"Jeremy G. Richman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeremy G. Richman","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121. Electronic address: jrichman@arenapharm.com","Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121. Electronic address: jrichman@arenapharm.com","institution_ids":["https://openalex.org/I4210126734"]},{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090636679","display_name":"Martha Kanemitsu-Parks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Kanemitsu-Parks","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081964759","display_name":"Ibragim Gaidarov","orcid":"https://orcid.org/0000-0002-0919-760X","observed_orcids":["https://orcid.org/0000-0002-0919-760X"]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ibragim Gaidarov","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034028247","display_name":"Jill S. Cameron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jill S. Cameron","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072062041","display_name":"Peter S. Griffin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Griffin","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hong Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Zheng","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023776029","display_name":"Nuvia C. Guerra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nuvia C. Guerra","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026907117","display_name":"Linda Cham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Cham","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036928263","display_name":"Dominique Maciejewski-Lenoir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominique Maciejewski-Lenoir","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049614797","display_name":"Dominic P. Behan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominic P. Behan","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037017590","display_name":"Doug Boatman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doug Boatman","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060964279","display_name":"Ruoping Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruoping Chen","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109094888","display_name":"Philip J. Skinner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Skinner","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032870634","display_name":"Pricilla Ornelas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pricilla Ornelas","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053116098","display_name":"M. Gerard Waters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Gerard Waters","raw_affiliation_strings":["Division of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey 07065"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey 07065","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076210539","display_name":"Samuel D. Wright","orcid":"https://orcid.org/0000-0001-5583-0595","observed_orcids":["https://orcid.org/0000-0001-5583-0595"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel D. Wright","raw_affiliation_strings":["Division of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey 07065"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey 07065","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016296935","display_name":"Graeme Semple","orcid":"https://orcid.org/0000-0002-9666-1588","observed_orcids":["https://orcid.org/0000-0002-9666-1588"]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Graeme Semple","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111754371","display_name":"Daniel T. Connolly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel T. Connolly","raw_affiliation_strings":["Arena Pharmaceuticals, Inc., San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, Inc., San Diego, California 92121","institution_ids":["https://openalex.org/I4210126734"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110484231"],"corresponding_institution_ids":["https://openalex.org/I4210126734"],"apc_list":{"value":3430,"currency":"USD","value_usd":3430},"apc_paid":{"value":3430,"currency":"USD","value_usd":3430},"fwci":2.9047,"has_fulltext":false,"cited_by_count":102,"citation_normalized_percentile":{"value":0.9205869,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"282","issue":"25","first_page":"18028","last_page":"18036"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6352999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6352999806404114,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.1143999993801117,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.05550000071525574,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gpr109a","display_name":"GPR109A","score":1.0},{"id":"https://openalex.org/keywords/prostaglandin-d2","display_name":"prostaglandin D2","score":0.9179999828338623},{"id":"https://openalex.org/keywords/lipolysis-inhibition","display_name":"lipolysis inhibition","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.5879999995231628},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/receptor-internalization","display_name":"receptor internalization","score":0.9409999847412109},{"id":"https://openalex.org/keywords/signal-transduction","display_name":"signal transduction","score":0.7429999709129333},{"id":"https://openalex.org/keywords/selective-agonists","display_name":"selective agonists","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C2776207758","wikidata":"https://www.wikidata.org/wiki/Q5303302","display_name":"Downstream (manufacturing)","level":2,"score":0.7464735507965088},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.677823543548584},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.552726686000824},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5363216996192932},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5338135361671448},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.46435239911079407},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.384156733751297},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2613460421562195},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.07841706275939941},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000273","descriptor_name":"Adipose Tissue","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002522","descriptor_name":"Chlorocebus aethiops","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015230","descriptor_name":"Prostaglandin D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019556","descriptor_name":"COS Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1074/jbc.m701866200","doi":"https://doi.org/10.1074/jbc.m701866200","is_oa":true,"landing_page_url":"https://doi.org/10.1074/jbc.m701866200","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},{"id":"pmid:17452318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17452318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of biological chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1074/jbc.m701866200","doi":"https://doi.org/10.1074/jbc.m701866200","is_oa":true,"landing_page_url":"https://doi.org/10.1074/jbc.m701866200","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1963817582","https://openalex.org/W1973053270","https://openalex.org/W1983693956","https://openalex.org/W1988179941","https://openalex.org/W1988283362","https://openalex.org/W1996819821","https://openalex.org/W2004243328","https://openalex.org/W2017663351","https://openalex.org/W2018007412","https://openalex.org/W2020459609","https://openalex.org/W2040822208","https://openalex.org/W2062149361","https://openalex.org/W2071741407","https://openalex.org/W2081128554","https://openalex.org/W2086933863","https://openalex.org/W2089505657","https://openalex.org/W2090600090","https://openalex.org/W2098346876","https://openalex.org/W2099559324","https://openalex.org/W2103682415","https://openalex.org/W2136868680","https://openalex.org/W2145034104","https://openalex.org/W2158025896","https://openalex.org/W2164339448","https://openalex.org/W2168443670","https://openalex.org/W2239233434","https://openalex.org/W2725187802","https://openalex.org/W4244097459","https://openalex.org/W4390186718"],"related_works":["https://openalex.org/W1973053270","https://openalex.org/W3165170661","https://openalex.org/W2363107529","https://openalex.org/W2168336490","https://openalex.org/W1981002997","https://openalex.org/W155997882","https://openalex.org/W2089505657","https://openalex.org/W3007981967","https://openalex.org/W2037637780","https://openalex.org/W2119328183"],"abstract_inverted_index":{"Nicotinic":[0],"acid":[1,27,179],"remains":[2],"the":[3,9,79,90,99,104,109,129,135,138,175,198,206],"most":[4],"effective":[5],"therapeutic":[6,23],"agent":[7],"for":[8],"treatment":[10],"and":[11,42,54,111,117,160,163],"prevention":[12],"of":[13,25,59,76,92,126,137,147,154,177,193,205],"atherosclerosis":[14],"resulting":[15],"from":[16,95],"low":[17],"high":[18,60],"density":[19,61],"lipoprotein":[20,62],"cholesterol.":[21],"The":[22,57,81],"actions":[24],"nicotinic":[26,178],"are":[28,115,124,152],"mediated":[29,88],"by":[30,73,89],"GPR109A,":[31],"a":[32,45,145,169,182],"Gi":[33],"protein-coupled":[34],"receptor,":[35],"expressed":[36],"primarily":[37],"on":[38],"adipocytes,":[39],"Langerhans":[40,96],"cells,":[41],"macrophage.":[43],"Unfortunately,":[44],"severe,":[46],"cutaneous":[47],"flushing":[48,82,170,190],"side":[49,83],"effect":[50,84],"limits":[51],"its":[52],"use":[53],"patient":[55],"compliance.":[56],"mechanism":[58],"elevation":[63],"is":[64],"not":[65,164],"clearly":[66],"established":[67],"but":[68,172],"assumed":[69],"to":[70,86,167,180,189,197,202,209],"be":[71,87,121],"influenced":[72],"an":[74],"inhibition":[75],"lipolysis":[77,157],"in":[78,98,158,161,185],"adipose.":[80],"appears":[85],"release":[91],"prostaglandin":[93,112],"D2":[94],"cells":[97,194],"skin.":[100],"We":[101,142],"hypothesized":[102],"that":[103,118,123,151],"signal":[105],"transduction":[106],"pathways":[107,114],"mediating":[108],"anti-lipolytic":[110,131],"D2/flushing":[113],"distinct":[116],"agonists":[119,150,200],"may":[120],"identified":[122,144],"capable":[125,153],"selectively":[127],"eliciting":[128],"therapeutic,":[130],"pathway":[132],"while":[133],"avoiding":[134],"activation":[136],"parallel":[139],"flush-inducing":[140],"pathway.":[141],"have":[143],"number":[146],"GPR109A":[148,196],"pyrazole":[149],"fully":[155],"inhibiting":[156],"vitro":[159],"vivo":[162],"only":[165],"fail":[166],"elicit":[168,181],"response":[171,184],"can":[173],"antagonize":[174],"ability":[176],"flush":[183],"vivo.":[186],"In":[187],"contrast":[188],"agonists,":[191],"exposure":[192],"expressing":[195],"non-flushing":[199],"fails":[201],"induce":[203],"internalization":[204],"receptor":[207],"or":[208],"activate":[210],"ERK":[211],"1/2":[212],"mitogen-activated":[213],"protein":[214],"kinase":[215],"phosphorylation.":[216]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1985018554","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
